Research Radar — 2026-07-02
Methods & AI
Computational
A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells
Nature Biotechnology Published 2026-07-01 research article DOI: 10.1038/s41587-026-03199-w
CRISPR screen perturbation stem cell gene regulation functional genomics
Summary: This study generates a genome-scale CRISPRi perturbation atlas in human induced pluripotent stem cells, systematically mapping transcriptional regulatory networks across the genome. By profiling the effects of thousands of knockdowns on gene expression, the resource reveals key regulators of pluripotency, differentiation, and cell identity. The atlas establishes a foundational reference for understanding gene regulation in stem cells and beyond.
Why it matters: Provides the first comprehensive transcriptional regulatory map of human pluripotent stem cells at genome scale, setting a new benchmark for functional genomics and perturbation-based gene regulatory network inference.
Why for Yiru: Directly relevant to my interest in CRISPR screens and perturbation biology — this atlas provides a reference framework for designing and interpreting perturbation screens in immune cells and cancer models.
BulkFormer: A large-scale foundation model for bulk transcriptomes
Cell Systems Published 2026-06-30 research article DOI: 10.1016/j.cels.2026.101657
foundation model transcriptomics deep learning representation learning RNA-seq
Summary: Kang et al. present BulkFormer, a foundation model pretrained on large-scale human bulk RNA-seq profiles that captures gene-gene interactions and expression context. The model improves performance across diverse bulk transcriptome tasks, and the study demonstrates that pretraining data modality is a key determinant of downstream foundation model performance.
Why it matters: Challenges the prevailing single-cell-centric paradigm for transcriptomic foundation models by showing that bulk RNA-seq pretraining can outperform single-cell pretraining for many important downstream tasks.
Why for Yiru: Directly applicable to my research on multi-omics integration and biomarker discovery in cancer immunotherapy — BulkFormer's approach to modeling gene interactions could enhance my analysis of bulk transcriptomic data from tumor microenvironments.
Tabular Foundation Models Are Competitive Cellular Perturbation Predictors Across Biological Scales
bioRxiv Published 2026-06-30 research article DOI: 10.64898/2026.06.28.735106v1
foundation model perturbation prediction single-cell deep learning CRISPR screen
Summary: General-purpose tabular foundation models (TabICL, TabPFN) outperform specialized single-cell foundation models (scGPT, scLAMBDA, PRESAGE, STACK, Prophet) at perturbation prediction across cell-level, pseudobulk, and whole-embryo settings. This demonstrates that in-context learning on tabular data provides a strong and scalable alternative to domain-specific architectures for biological prediction.
Why it matters: Challenges the assumption that domain-specific foundation models are necessary for biological tasks, with significant implications for how the field designs and deploys AI models for perturbation biology.
Why for Yiru: Highly relevant to my work on perturbation prediction and single-cell analysis — tabular in-context learning could simplify my modeling pipeline for predicting immune cell responses to genetic perturbations.
MintCNA: A Unified Framework for Integrative Copy Number Profiling with Single-Cell Multi-Omics Data
bioRxiv Published 2026-06-30 research article DOI: 10.64898/2026.06.26.734559v1
single-cell multi-omics copy number alteration deep learning cancer genomics
Summary: MintCNA integrates statistical modeling with deep learning to detect copy number alterations from paired single-cell multi-omics data. Its attention-guided convolutional autoencoder denoises the signal while multivariate change-point detection identifies genome-wide chromosomal breakpoints, outperforming existing single-omics CNA callers.
Why it matters: Fills a critical gap in single-cell multi-omics analysis by providing a unified CNA caller that leverages information across data modalities, improving accuracy for cancer genomics applications.
Why for Yiru: Relevant to my work on multi-omics and cancer genomics — MintCNA's integrative approach for copy number profiling is useful for characterizing genomic instability in tumor immune microenvironments.
ClairS: a deep-learning method for long-read tumor–normal pair somatic small variant calling
Nature Methods Published 2026-07-01 research article DOI: 10.1038/s41592-026-03152-4
deep learning variant calling long-read sequencing cancer genomics somatic mutation
Summary: ClairS applies deep learning to accurately detect somatic small variants from long-read sequencing data of tumor-normal pairs. It addresses the unique challenges of long-read data, including higher error rates and complex alignment patterns, achieving high accuracy for cancer genomics applications.
Why it matters: As long-read sequencing becomes increasingly adopted in cancer genomics, accurate somatic variant calling from this data type is essential for precision oncology and translational research.
Why for Yiru: Somatic variant calling is foundational to cancer genomics — this long-read approach may improve mutation detection sensitivity in my tumor microenvironment studies.
Penumbria: Advanced 3D cell segmentation for biomedical imaging
bioRxiv Published 2026-06-30 research article DOI: 10.64898/2026.06.30.735527v1
cell segmentation deep learning 3D imaging microscopy image analysis
Summary: Penumbria is a general-purpose 3D cell segmentation framework using U-Net with xLSTM bottleneck blocks, a Global Zernike Phase Layer for optical aberration correction, and a Scaled Geocaps Layer for multi-scale feature routing. It achieves state-of-the-art accuracy across diverse cell morphologies and imaging conditions, outperforming Cellpose-SAM and StarDist-3D.
Why it matters: Advances the state of the art in 3D cell segmentation, a critical bottleneck for high-content imaging and spatial biology at single-cell resolution.
Why for Yiru: While not my primary focus, advances in cell segmentation are relevant to spatial omics and imaging-based tissue analysis of the tumor microenvironment.
Biomedical discoveries
Biomedicine
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer
Nature Published 2026-07-01 research article DOI: 10.1038/s41586-026-10705-2
colorectal cancer cell state plasticity antibody-drug conjugate TROP2
Summary: TROP2 is identified as a marker of poor-prognosis colorectal cancer cells that adopt fetal-like, therapy-resistant cell states. Therapeutic targeting of TROP2 with antibody-drug conjugates in combination with chemotherapy modulates tumor cell plasticity and overcomes resistance, revealing a targetable axis of therapy-driven cell state dynamics in CRC.
Why it matters: Identifies a novel mechanism of therapy-driven cell plasticity in colorectal cancer and provides a viable therapeutic strategy using TROP2-directed ADCs to target resistant cell states.
Why for Yiru: Cell state dynamics and plasticity in cancer are central to understanding immunotherapy resistance — this TROP2 axis may have parallel mechanisms in immune evasion that could be explored using single-cell and spatial omics approaches.
Nur77 agonism invigorates Natural Killer cell immunity against hepatocellular carcinoma
Nature Communications Published 2026-06-30 research article DOI: 10.1038/s41467-026-75027-3
NK cell hepatocellular carcinoma immunotherapy organoid Nur77
Summary: Nuclear receptor Nur77 promotes NK cell maturation and cytotoxicity by relieving lipid-mediated metabolic suppression and upregulating AP-1 response genes. Using patient-derived samples, organoid co-cultures, and preclinical HCC models, the authors demonstrate that Nur77 agonism enhances adoptive NK cell therapy efficacy.
Why it matters: Identifies a druggable nuclear receptor that enhances NK cell function through metabolic reprogramming, opening a new non-T-cell immunotherapy axis for hepatocellular carcinoma.
Why for Yiru: NK cell immunotherapies are directly relevant to my interests — the Nur77 mechanism could be explored in multi-omics profiling of the tumor immune microenvironment to identify predictive biomarkers for NK cell therapy.
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Published 2026-07-01 research article DOI: 10.1038/s41586-026-10641-1
CAR-T glioblastoma tumor microenvironment myeloid cells GPNMB
Summary: Integrated multi-omic profiling of glioblastoma reveals GPNMB as a shared antigen expressed by both tumor cells and tumor-associated myeloid cells in the microenvironment. GPNMB-targeted CAR-T cells demonstrate potent therapeutic activity in vitro and in animal models, enabling simultaneous targeting of malignant cells and the immunosuppressive myeloid compartment.
Why it matters: Pioneers a dual tumor–myeloid targeting strategy for CAR-T therapy in solid tumors, addressing the critical challenge of the immunosuppressive tumor microenvironment that limits current adoptive cell therapies.
Why for Yiru: Directly relevant to my work on CAR-T cell therapy and tumor microenvironment biology — this dual-targeting approach is a paradigm for engineering next-generation CAR-T cells to overcome solid tumor resistance.
Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion
Immunity Published 2026-06-29 research article DOI: 10.1016/j.immuni.2026.06.004
lactate STING immune evasion glycolysis immunotherapy
Summary: Tumor aerobic glycolysis drives lactate production through PKM2-mediated phosphorylation and activation of LDHA. Lactate is shown to directly bind to and inhibit the innate immune sensor STING, and targeting PKM2 attenuates lactate-dependent immune evasion and synergizes with anti-PD-1 therapy.
Why it matters: Reveals a direct mechanistic link between cancer aerobic glycolysis and STING inhibition via lactate, identifying PKM2 as a druggable target to overcome metabolic immune evasion and improve checkpoint immunotherapy.
Why for Yiru: The lactate-STING axis is a fascinating intersection of metabolism and innate immunity — highly relevant to my interests in tumor microenvironment remodeling and identifying combinatorial immunotherapy strategies.
Multi-compartment immune and tumor cell reprogramming by IFNa2 overcomes colon cancer immunotherapy resistance
bioRxiv Published 2026-06-30 research article DOI: 10.64898/2026.06.26.734809v1
immunotherapy tumor microenvironment IFNa2 single-cell colon cancer
Summary: LNP-encapsulated IFNa2 gene therapy systematically reprograms the tumor microenvironment: SPP1+ macrophages undergo apoptosis, Tpex cells expand, and tumor cells increase antigen presentation while losing hypoxia-driven cuproptosis resistance. Single-cell RNA-seq reveals coordinated multi-compartment remodeling that sensitizes tumors to immune checkpoint inhibitor therapy.
Why it matters: Demonstrates that type I interferon therapy can comprehensively reprogram both immune and tumor compartments to overcome immunotherapy resistance in colon cancer, with clear translational potential.
Why for Yiru: The multi-compartment scRNA-seq analysis of TME reprogramming is directly applicable to my research on characterizing and predicting immunotherapy response mechanisms using single-cell transcriptomics.
Self-antigen disrupts cDC1 mediated antitumor responses
bioRxiv Published 2026-06-29 research article DOI: 10.64898/2026.06.25.734634v1
dendritic cell antigen presentation tumor immunity cross-presentation CD8+ T cell
Summary: cDC1 dendritic cells that simultaneously process self and tumor antigens show reduced capacity to prime tumor-specific CD8+ T cells, as self-antigen biases peptide loading away from tumor epitopes. This reveals a fundamental mechanism by which self-antigen competition limits dendritic cell-mediated antitumor immunity.
Why it matters: Identifies self-antigen competition as a key inhibitory mechanism in dendritic cell cross-presentation, with direct implications for improving cancer vaccine design and DC-based immunotherapies.
Why for Yiru: Relevant to my interest in T cell priming and antigen presentation in the tumor microenvironment — modulating this self-antigen bias could enhance the efficacy of cancer vaccines and adoptive T cell therapies.
Cross-disciplinary watchlist
Other Fields
Putting numbers on chromatin looping
Nature Structural & Molecular Biology Published 2026-06-30 research article DOI: 10.1038/s41594-026-01817-4
chromatin looping genome organization Micro-C imaging gene regulation
Summary: Jusuf et al. estimate absolute chromatin looping probabilities genome-wide by calibrating deep Micro-C maps against live-cell imaging measurements. Their analysis reveals that most chromatin loops are rare events rather than stable structural elements, providing quantitative ground truth for genome organization.
Why it matters: Provides the first quantitative estimate of absolute chromatin looping probabilities, challenging assumptions about the stability of genome architecture and informing models of gene regulation.
Why for Yiru: While not directly in my research focus, understanding the physical principles of chromatin organization informs how gene regulatory programs are established in immune cells and cancer cells.
Towards the construction of a virtual yeast
Nature Published 2026-07-01 research article DOI: 10.1038/s41586-026-10574-9
virtual cell digital twin AI systems biology whole-cell modeling
Summary: A virtual yeast — an AI-driven agent for modeling eukaryotic cellular behaviors — represents a major milestone toward whole-cell computational modeling. The system integrates multi-scale biological data into a predictive digital twin capable of simulating complex cellular behaviors and responses to perturbations.
Why it matters: Establishes the first AI-driven digital twin of a eukaryotic cell, providing a blueprint for whole-cell modeling that could eventually transform how we predict drug responses and engineer cellular behavior.
Why for Yiru: Directly relevant to my interest in digital twin AI for biology — this framework provides a template for building predictive models of immune cell behavior and could inform my vision of patient-specific immune digital twins.
Identification of cross-stage, cross-species malaria CD8+ T cell antigens
Nature Published 2026-07-01 research article DOI: 10.1038/s41586-026-10730-1
malaria vaccine T cell immunopeptidomics antigen discovery
Summary: An immunopeptidomics analysis identifies Plasmodium T cell antigens that are conserved across parasite species and expressed across multiple life-cycle stages. These cross-stage, cross-species antigens provide promising candidates for broadly protective malaria vaccines.
Why it matters: Addresses a critical bottleneck in malaria vaccine development by identifying conserved T cell antigens that could provide broad, durable protection across diverse parasite strains.
Why for Yiru: The immunopeptidomics approach and systematic T cell antigen discovery pipeline are relevant to my interests in computational immunology and antigen prediction for cancer immunotherapy.
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC
Nature Published 2026-07-01 research article DOI: 10.1038/s41586-026-10686-2
colorectal cancer liver metastasis steatosis MYC metastasis heterogeneity
Summary: Liver steatosis promotes formation of replacement-type liver metastases in colorectal cancer by stabilizing MYC through acetylation, which increases proline synthesis and collagen production. This reveals how hepatic metabolic state governs metastasis heterogeneity and shapes patient prognosis.
Why it matters: Uncovers a clinically relevant mechanism linking host metabolic state (liver fat) to metastatic behavior in colorectal cancer, with implications for risk stratification and therapeutic targeting of liver metastases.
Why for Yiru: Cancer metastasis and tumor heterogeneity are central to my research — this metabolic-epigenetic crosstalk in the metastatic niche provides a compelling mechanism that could intersect with immune evasion in liver metastases.
Age-dependent disease tolerance to SARS-CoV-2 infection
bioRxiv Published 2026-06-29 research article DOI: 10.64898/2026.06.27.734955v1
aging COVID-19 lipid metabolism myelopoiesis disease tolerance
Summary: Age-related decline in adipose tissue lipolysis compromises disease tolerance to SARS-CoV-2. Adipocyte-derived free fatty acids support bone marrow emergency myelopoiesis via CD36/CPT1-mediated fatty acid oxidation, revealing a metabolic-immune circuit that sustains lung structure and function during infection.
Why it matters: Identifies an adipose-bone marrow-lung metabolic axis that explains age dependence of COVID-19 severity, opening new therapeutic avenues for improving disease tolerance in elderly populations.
Why for Yiru: The immunometabolic perspective on disease tolerance is interesting but tangential to my primary focus on cancer immunotherapy; the myelopoiesis regulation mechanism may have parallels in tumor-induced emergency myelopoiesis.
Systematic discovery of pathogen effector functions across human pathogens and pathways
Cell Published 2026-06-29 research article DOI: 10.1016/j.cell.2026.06.017
pathogen effector functional genomics screen host-pathogen
Summary: The eORFeome — a comprehensive collection of ORFs encoding viral proteins and secreted bacterial/parasite effectors — enables large-scale functional genomics across diverse host pathways. Pooled lentiviral screens identify hundreds of effectors that perturb NF-κB, p53, apoptosis, STING, and MHC-I pathways, revealing fundamental host-pathogen interaction mechanisms.
Why it matters: Transforms our understanding of host-pathogen interactions by providing a systematic functional resource for pathogen effector discovery at an unprecedented scale.
Why for Yiru: The functional genomics screening approach and immune pathway perturbation readouts are highly relevant to my work on CRISPR screens and pathway-level characterization of immune modulation in cancer.